[HTML] sciencedirect.com

[HTML][HTML] Inhalation of MSC-EVs is a noninvasive strategy for ameliorating acute lung injury

R Zhao, L Wang, T Wang, P Xian, H Wang… - Journal of Controlled …, 2022 - Elsevier
Mesenchymal stem cell-derived small extracellular vesicles (MSC-EVs) are promising
nanotherapeutic agent for pneumonia (bacterial origin, COVID-19), but the optimal …
被引用次数：47 相关文章

Inhalation of MSC-EVs is a noninvasive strategy for ameliorating acute lung injury.

R Zhao, L Wang, T Wang, P Xian, H Wang… - Journal of Controlled …, 2022 - europepmc.org
Mesenchymal stem cell-derived small extracellular vesicles (MSC-EVs) are promising
nanotherapeutic agent for pneumonia (bacterial origin, COVID-19), but the optimal …

Inhalation of MSC-EVs is a noninvasive strategy for ameliorating acute lung injury

R Zhao, L Wang, T Wang, P Xian… - … : official journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Mesenchymal stem cell-derived small extracellular vesicles (MSC-EVs) are promising
nanotherapeutic agent for pneumonia (bacterial origin, COVID-19), but the optimal …
[PDF] researchgate.net

[PDF][PDF] Inhalation of MSC-EVs is a noninvasive strategy for ameliorating acute lung injury

R Zhao, L Wang, T Wang, P Xian… - Journal of Controlled …, 2022 - researchgate.net
Mesenchymal stem cell-derived small extracellular vesicles (MSC-EVs) are promising
nanotherapeutic agent for pneumonia (bacterial origin, COVID-19), but the optimal …

[引用][C] Inhalation of MSC-EVs is a noninvasive strategy for ameliorating acute lung injury

R Zhao, L Wang, T Wang, P Xian, H Wang, Q Long - 2022